Loading company
Tactile Systems Technology Inc.
TCMD · Nasdaq · ·
Next earnings: November 2, 2026
$22.55-1.1%Sep 29 close
- 1M
- -2.6%
- 6M
- -12.9%
- 1Y
- +62.9%
- 5Y
- -49.7%
TCMD · Nasdaq · ·
Next earnings: November 2, 2026
$22.55-1.1%Sep 29 close
Tactile Systems Technology Inc. is scheduled to report next on November 2, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $85.7M | $78.9M | +8.61% |
| Profit | $7.8M | $3.2M | +142.00% |
| Profit per share | $0.34 | $0.14 | +142.86% |
| Free Cash Flow | $2M | $14.4M | -86.29% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“We are encouraged by our strong momentum in the second quarter. We delivered solid revenue growth, expanded gross margin, and generated meaningful adjusted EBITDA, underscoring the strength of our business model and our team’s disciplined execution,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
Systems Technology, Inc. (DBA Tactile Medical) Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic respiratory conditions by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year. Legal Notice Regarding
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Tactile Systems Technology Inc.’s Item 2.02 8-K filed August 10, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Tactile Systems Technology Inc. has no earnings call transcript available.